Brief: Wockhardt Says Zaynich Successful Used To Treat Cancer Patient In U.S. With Chronic Bilateral Thigh Infection
28/06/2024 11:45
June 28 (Reuters) - Wockhardt Ltd WCKH.NS :
* SUCCESSFUL USE OF INVESTIGATIONAL ANTIBIOTIC, ZAYNICH TO
TREAT
CANCER PATIENT IN U.S. WITH CHRONIC BILATERAL THIGH INFECTION
Source text for Eikon: ID:nNSE6DLzsQ
Further company coverage: WCKH.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Wockhardt
See all newsBrief: Wockhardt Says Customs Authority Imposes 50 Million Rupees Penalty And 100 Million Rupees Redemption Fine On Co
Brief: Wockhardt Limited June-Quarter Consol Net Profit 1.06 Billion Rupees
India's Wockhardt gains after marketing authorization for antibiotic ZAYNICH
Brief: Wockhardt Says Indian Drug Regulator Grants Marketing Authorization To Co's Zaynich
India's Wockhardt hits 7‑month high after swinging to profit in fourth quarter